Vermillion, Inc. (Nasdaq: VRML) to Ring The Nasdaq Stock Market Closing Bell
August 31 2016 - 10:00AM
What:
Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions
company focused on gynecologic disease, will visit the Nasdaq
MarketSite in Times Square, to help kick off Ovarian Cancer
Awareness Month.
In honor of the occasion, Valerie Palmieri, President
and Chief Executive Officer, will ring the Closing Bell
along with OVA1 Blood Test Spokespersons:
- Shannon Miller- America’s Most Decorated Olympic Gymnast &
Ovarian Cancer survivor
- Sherry Pollex- Life partner of NASCAR Driver Martin Truex, Jr.
and Ovarian Cancer Survivor
Where: Nasdaq MarketSite – 4 Times Square
– 43rd & Broadway – Broadcast Studio
When: Thursday, September 1, 2016 – 3:45
p.m. to 4:00 p.m. ET
Vermillion Contact: Katie Leighton (610)
513-6930 Katie@LeightonPR.com
Nasdaq MarketSite: Emily Pan (646)
441-5120 emily.pan@nasdaq.com
Feed Information: Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media: For multimedia features such
as exclusive content, photo postings, status updates and video of
bell ceremonies, please visit our Facebook
page: http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page: http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page: http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page: http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page: http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Vermillion Vermillion, Inc. is
dedicated to the discovery, development and commercialization of
novel high-value diagnostic and bio-analytical solutions that help
physicians diagnose, treat and improve gynecologic health outcomes
for women. Vermillion, along with its prestigious scientific
collaborators, discovers, develops, and delivers innovative
diagnostic and technology tools that help women with serious
diseases. The company’s initial in vitro diagnostic test, OVA1®,
was the first FDA-cleared, protein-based In Vitro Diagnostic
Multivariate Index Assay, and represented a new class of
software-based liquid biopsy in vitro diagnostics. In March 2016,
Vermillion received FDA clearance for Overa™, a second generation
OVA1 test with significantly improved specificity and ease of use.
For additional information, including published clinical trials,
visit www.vermillion.com.
About Nasdaq Nasdaq (Nasdaq:NDAQ) is a
leading provider of trading, clearing, exchange technology,
listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq
enables customers to plan, optimize and execute their business
vision with confidence, using proven technologies that provide
transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock
market, its technology powers more than 70 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to more than 3,700 listed companies with a market
value of approximately $9.3 trillion and nearly 18,000 corporate
clients. To learn more, visit: nasdaq.com/ambition or
business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2023 to Mar 2024